Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E de Jonge

Showing results (111-120 of 126) with videos related to

Pageof 13
Sort By:
Basic & Clinical Pharmacology & Toxicology|January 26, 2005
Population pharmacokinetics of caffeine and its metabolites theobromine, paraxanthine and theophylline after inhalation in combination with diacetylmorphineAnthe S Zandvliet, Alwin D R Huitema, Milly E de Jonge, et al.
Journal of Thrombosis and Haemostasis : JTH|January 14, 2004
Recombinant nematode anticoagulant protein c2, an inhibitor of tissue factor/factor VIIa, attenuates coagulation and the interleukin-10 response in human endotoxemiaA C J M de Pont, A H M Moons, E de Jonge, et al.
European Journal of Cancer (Oxford, England : 1990)|May 29, 2007
Upregulation of Wilms' tumour gene 1 (WT1) in uterine sarcomasA Coosemans, S Amini Nik, S Caluwaerts, et al.
Breast Cancer Research and Treatment|May 24, 2023
Plasma ESR1 mutations and outcome to first-line paclitaxel and bevacizumab in patients with advanced ER-positive/HER2-negative breast cancerM K Bos, S W Lam, G Motta, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 10, 2004
Bayesian pharmacokinetically guided dosing of paclitaxel in patients with non-small cell lung cancerMilly E de Jonge, H J G Desirée van den Bongard, Alwin D R Huitema, et al.
Critical Care (London, England)|October 1, 2018
Carriage of antibiotic-resistant Gram-negative bacteria after discontinuation of selective decontamination of the digestive tract (SDD) or selective oropharyngeal decontamination (SOD)E de Jonge, R B P de Wilde, N P Juffermans, et al.
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology|March 11, 2010
Prospective external validation of the 'ovarian crescent sign' as a single ultrasound parameter to distinguish between benign and malignant adnexal pathologyC Van Holsbeke, V Van Belle, F P G Leone, et al.
Clinical Pharmacology and Therapeutics|May 24, 2012
Effects of CYP induction by rifampicin on tamoxifen exposureL Binkhorst, T van Gelder, W J Loos, et al.
Blood|July 11, 2000
The in vivo kinetics of tissue factor messenger RNA expression during human endotoxemia: relationship with activation of coagulationR F Franco, E de Jonge, P E Dekkers, et al.
Journal of Psychiatric Research|October 7, 2021
Ethnic discrimination and depressed mood: The role of autonomic regulationJulia M Hagen, Arjen L Sutterland, Didier Collard, et al.
Pageof 13

Showing results (111-120 of 126) with videos related to

Sort By:
Pageof 13
Basic & Clinical Pharmacology & Toxicology|January 26, 2005
Population pharmacokinetics of caffeine and its metabolites theobromine, paraxanthine and theophylline after inhalation in combination with diacetylmorphineAnthe S Zandvliet, Alwin D R Huitema, Milly E de Jonge, et al.
Journal of Thrombosis and Haemostasis : JTH|January 14, 2004
Recombinant nematode anticoagulant protein c2, an inhibitor of tissue factor/factor VIIa, attenuates coagulation and the interleukin-10 response in human endotoxemiaA C J M de Pont, A H M Moons, E de Jonge, et al.
European Journal of Cancer (Oxford, England : 1990)|May 29, 2007
Upregulation of Wilms' tumour gene 1 (WT1) in uterine sarcomasA Coosemans, S Amini Nik, S Caluwaerts, et al.
Breast Cancer Research and Treatment|May 24, 2023
Plasma ESR1 mutations and outcome to first-line paclitaxel and bevacizumab in patients with advanced ER-positive/HER2-negative breast cancerM K Bos, S W Lam, G Motta, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 10, 2004
Bayesian pharmacokinetically guided dosing of paclitaxel in patients with non-small cell lung cancerMilly E de Jonge, H J G Desirée van den Bongard, Alwin D R Huitema, et al.
Critical Care (London, England)|October 1, 2018
Carriage of antibiotic-resistant Gram-negative bacteria after discontinuation of selective decontamination of the digestive tract (SDD) or selective oropharyngeal decontamination (SOD)E de Jonge, R B P de Wilde, N P Juffermans, et al.
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology|March 11, 2010
Prospective external validation of the 'ovarian crescent sign' as a single ultrasound parameter to distinguish between benign and malignant adnexal pathologyC Van Holsbeke, V Van Belle, F P G Leone, et al.
Clinical Pharmacology and Therapeutics|May 24, 2012
Effects of CYP induction by rifampicin on tamoxifen exposureL Binkhorst, T van Gelder, W J Loos, et al.
Blood|July 11, 2000
The in vivo kinetics of tissue factor messenger RNA expression during human endotoxemia: relationship with activation of coagulationR F Franco, E de Jonge, P E Dekkers, et al.
Journal of Psychiatric Research|October 7, 2021
Ethnic discrimination and depressed mood: The role of autonomic regulationJulia M Hagen, Arjen L Sutterland, Didier Collard, et al.
Pageof 13